These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 28449205)

  • 1. Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (IMPACT): a randomized controlled trial.
    Siaw MYL; Ko Y; Malone DC; Tsou KYK; Lew YJ; Foo D; Tan E; Chan SC; Chia A; Sinaram SS; Goh KC; Lee JY
    J Clin Pharm Ther; 2017 Aug; 42(4):475-482. PubMed ID: 28449205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of multidisciplinary collaborative care versus usual care in the management of high-risk patients with diabetes in Singapore: Short-term results from a randomized controlled trial.
    Siaw MYL; Malone DC; Ko Y; Lee JY
    J Clin Pharm Ther; 2018 Dec; 43(6):775-783. PubMed ID: 29696669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
    Korcegez EI; Sancar M; Demirkan K
    J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing economic burden through split-shared care model for people living with uncontrolled type 2 diabetes and polypharmacy: a multi-center randomized controlled trial.
    Lum ZK; Tan JY; Wong CSM; Kok ZY; Kwek SC; Tsou KYK; Gallagher PJ; Lee JY
    BMC Health Serv Res; 2024 Jun; 24(1):760. PubMed ID: 38907254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a diabetes collaborative care management program on clinical and economic outcomes in patients with type 2 diabetes.
    McAdam-Marx C; Dahal A; Jennings B; Singhal M; Gunning K
    J Manag Care Spec Pharm; 2015 Jun; 21(6):452-68. PubMed ID: 26011547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of pharmacist care on diabetes outcomes in primary care settings: An umbrella review of published systematic reviews.
    Abdulrhim S; Sankaralingam S; Ibrahim MIM; Awaisu A
    Prim Care Diabetes; 2020 Oct; 14(5):393-400. PubMed ID: 31926868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
    Ali MK; Chwastiak L; Poongothai S; Emmert-Fees KMF; Patel SA; Anjana RM; Sagar R; Shankar R; Sridhar GR; Kosuri M; Sosale AR; Sosale B; Rao D; Tandon N; Narayan KMV; Mohan V;
    JAMA; 2020 Aug; 324(7):651-662. PubMed ID: 32809002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist Intervention for Blood Pressure Control in Patients with Diabetes and/or Chronic Kidney Disease.
    Anderegg MD; Gums TH; Uribe L; MacLaughlin EJ; Hoehns J; Bazaldua OV; Ives TJ; Hahn DL; Coffey CS; Carter BL
    Pharmacotherapy; 2018 Mar; 38(3):309-318. PubMed ID: 29331037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of collaborative pharmaceutical care on in-patients' medication safety: study protocol for a stepped wedge cluster randomized trial (MEDREV study).
    Leguelinel-Blache G; Castelli C; Roux-Marson C; Bouvet S; Andrieu S; Cestac P; Collomp R; Landais P; Loulière B; Mouchoux C; Varin R; Allenet B; ; Bedouch P; Kinowski JM
    Trials; 2018 Jan; 19(1):19. PubMed ID: 29310711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a community pharmacy-based medication therapy management program on clinical and humanistic outcomes in patients with uncontrolled diabetes: a randomised controlled trial.
    Albabtain B; Bawazeer G; Paudyal V; Cheema E; Alqahtani A; Bahatheq A; Price MJ; Hadi MA
    Sci Rep; 2024 Aug; 14(1):17818. PubMed ID: 39090152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist-physician collaborative care model for patients with uncontrolled type 2 diabetes in Brazil: results from a randomized controlled trial.
    Aguiar PM; da Silva CHP; Chiann C; Dórea EL; Lyra DP; Storpirtis S
    J Eval Clin Pract; 2018 Feb; 24(1):22-30. PubMed ID: 27452158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacist intervention and the proportion of diabetes patients attaining prevention objectives in a multispecialty medical group.
    Padiyara RS; D'Souza JJ; Rihani RS
    J Manag Care Pharm; 2011; 17(6):456-62. PubMed ID: 21787031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving outcomes for diverse populations disproportionately affected by diabetes: final results of Project IMPACT: Diabetes.
    Bluml BM; Watson LL; Skelton JB; Manolakis PG; Brock KA
    J Am Pharm Assoc (2003); 2014; 54(5):477-85. PubMed ID: 25216877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first pharmacist-managed anticoagulation clinic under a collaborative practice agreement in Qatar: clinical and patient-oriented outcomes.
    Elewa HF; AbdelSamad O; Elmubark AE; Al-Taweel HM; Mohamed A; Kheir N; Mohamed Ibrahim MI; Awaisu A
    J Clin Pharm Ther; 2016 Aug; 41(4):403-8. PubMed ID: 27144477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).
    McLean DL; McAlister FA; Johnson JA; King KM; Makowsky MJ; Jones CA; Tsuyuki RT;
    Arch Intern Med; 2008 Nov; 168(21):2355-61. PubMed ID: 19029501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial to assess pharmacist- physician collaborative practice in the management of metabolic syndrome in a university medical clinic in Jordan.
    Hammad EA; Yasein N; Tahaineh L; Albsoul-Younes AM
    J Manag Care Pharm; 2011 May; 17(4):295-303. PubMed ID: 21534640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing diabetes care with community pharmacist-involved collaborative care model: A multi-centre randomised controlled trial.
    Lum ZK; Chang KL; Tsou KY; Tan JY; Wong CSM; Kok ZY; Kwek SC; Gallagher PJ; Lee JY
    Diabetes Res Clin Pract; 2022 Mar; 185():109238. PubMed ID: 35131378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic outcomes of pharmacist-physician medication therapy management for polypharmacy elderly: A prospective, randomized, controlled trial.
    Lin HW; Lin CH; Chang CK; Chou CY; Yu IW; Lin CC; Li TC; Li CI; Hsieh YW
    J Formos Med Assoc; 2018 Mar; 117(3):235-243. PubMed ID: 28549592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: results from a randomized controlled trial.
    Simpson SH; Lier DA; Majumdar SR; Tsuyuki RT; Lewanczuk RZ; Spooner R; Johnson JA
    Diabet Med; 2015 Jul; 32(7):899-906. PubMed ID: 25594919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.